Skip to content

Pulsed Electromagnetic Field (PEMF) Systems to Promote the Maintenance of Bone and Muscle

A Randomized, Sham-Controlled Pilot Study of Pulsed Electromagnetic Field Therapy in Promoting the Maintenance of Muscle Following Anterior Cruciate Ligament (ACL) Reconstruction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03165318
Enrollment
22
Registered
2017-05-24
Start date
2017-03-07
Completion date
2018-07-31
Last updated
2017-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Loss Post Anterior Cruciate Ligament Reconstruction

Keywords

Pulsed electromagnetic field, Anterior cruciate ligament reconstruction, Muscle

Brief summary

This is a pilot study that evaluates the effect of PEMF in maintaining muscle mass postoperatively in individuals experiencing clinical immobilisation due ACL reconstruction surgery. Half of the participants will receive the PEMF therapy in combination with standard rehabilitation programme, while the other half will receive sham therapy in combination with standard rehabilitation programme.

Detailed description

This is a single-site, randomized, double-blinded, prospective pilot study of the effectiveness of once-weekly PEMF therapy in the promotion of muscle maintenance following ACL reconstruction surgery. Eligible subjects will be randomized in a 1:1 ratio to receive therapy with an active PEMF device or an identical inactive Sham device, in addition to the standard rehabilitation regimen.

Interventions

Participants of this arm will be exposed to 10 minutes of Pulsed Electromagnetic Field (PEMF) once a week for a total of 16 weeks. The PEMF device produces pulsed magnetic fields at flux densities up to 1 mT peak.

DEVICESham Therapy

Participants of this arm will be exposed to 10 minutes of sham therapy once a week for a total of 16 weeks. The Sham device is identical to the PEMF device in physical appearance.

Sponsors

National University of Singapore
CollaboratorOTHER
National University Hospital, Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Subjects who have undergone unilateral first-time athroscopic reconstruction with single bundle hamstring graft using both transtibial and transportal techniques for rupture anterior cruciate ligament * Informed consent signed

Exclusion criteria

* Subjects requiring concomitant knee ligament reconstruction * Subjects having other than hamstring graft for the ACL reconstruction * Subjects with history of cardiac, neurological, and rheumatological diseases, and previous lower limb surgery/ fracture * Subjects with Leg circumference \> 63 cm * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Muscle VolumeWeek 1 and Week 16 post-ACL reconstruction% change in muscle volume at the end of 16 weeks compared to baseline

Secondary

MeasureTime frameDescription
Quadriceps strengthBaseline and Week 8, 12, 16 post-ACL reconstructionQuadricep strength (Ib) measurement by dynamometer
Knee and thigh circumferenceBaseline and Week 1, 4, 8, 12, 16 post-ACL reconstructionMeasurement of knee girth (cm) from mid portion of the patella and thigh girth (cm) 5 cm above from the superior border of the patella
Knee Injury and Osteoarthritis Outcome Score (KOOS)Week 16 post-ACL reconstructionKnee Injury and Osteoarthritis Outcome Score (KOOS): a validated knee-specific instrument that measures the short-term and long-term symptoms and function associated with knee injury. KOOS consists of 5 subscales: pain, other symptoms, function in daily living, function in sport and recreation, and knee related quality of life.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026